NCT05782114

Brief Summary

The current study will be conducted to explore the efficacy of ESWT on ultrasonographic changes, pain intensity level, upper limb function and hand grip strength in patients with de Quervain tenosynovitis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 23, 2023

Completed
9 days until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

March 23, 2023

Status Verified

March 1, 2023

Enrollment Period

1 year

First QC Date

March 12, 2023

Last Update Submit

March 12, 2023

Conditions

Keywords

Extracorporeal Shockwave therapy :ESWTUltrasonography USHandGrip StrenghtDe Quervain Tenosynovitis

Outcome Measures

Primary Outcomes (2)

  • Ultrasonographic Changes: Thickness in tendons:

    Ultrasonography which is a valid and reliable measure to evaluate tendon structural changes including: 1. Tendon thickness APL \& EPB tendons in mm. 2. Thickness of hypoechoic area in mm.

    Up to Four weeks

  • Ultrasonographic Changes: Color Doppler activity

    Ultrasonography

    Up to Four weeks

Secondary Outcomes (4)

  • Pain intensity level assessment :

    Up to Four weeks

  • Assessment of upper limb function:

    Up to Four weeks

  • Handgrip Strength assessment:

    Up to Four weeks

  • Pinch grip Strength assessment:

    Up to Four weeks

Study Arms (2)

The experimental Group A

EXPERIMENTAL

Extracorporeal Shockwave therapy (four sessions one session per week) +Traditional physical therapy program (Instruction to wear Thumb Spica splint, Ultrasound therapy, stretching exercise \& strengthening exercise) (two sessions per week for 4 weeks).

Other: Extracorporeal Shockwave therapyOther: Traditional physical therapy program

The control Group B

ACTIVE COMPARATOR

Traditional physical therapy program (Instruction to wear Thumb Spica splint, Ultrasound therapy, stretching exercise \& strengthening exercise) (two sessions per week for 4 weeks).

Other: Traditional physical therapy program

Interventions

The shockwave will be applied for the experimental group (Group A). The patients will be positioned on a chair, and the hand with the disorder will be placed on a surface with the radio ulnar joint will be in mid position and the thumb will be directed up. will be 1000 impulses with 2 bar pressure at a frequency of 15 Hz on the radial head and focused on the tissue surrounding the maximal pain point.

The experimental Group A

1. Instruction to wear Thumb Spica splint: The Thumb Spica splint will be used for 4 weeks for both groups of patients. 2. Ultrasound Therapy: Therapeutic Ultrasound parameters will be mode: continuous, duration: 5 minutes, intensity: 1.2watt/cm2 and frequency: 1MHZ. 3. Stretching exercise: 1\. Self-stretch of the thenar eminence: 2. Opposition stretches: 3. Wrist stretch: 4\) Strengthening exercise: 1. Resisted exercise for thumb extension: 2. Resisted exercise for thumb abduction: 3. Resisted exercise for thumb opposition: 4. Wrist radial deviation strengthening: 5. Grip strengthening: 6. Finger spring:

The control Group BThe experimental Group A

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age from 18 to 65 years
  • Both genders (males and females).
  • Normal BMI ranges between 18.5:24.9 kg/m2.
  • Patients will be referred from an orthopedist with diagnosis of DQT.
  • Chronic pain more than 2 months.
  • No history of undergoing physiotherapy modalities or corticosterone injection therapies for any reasons during the past month.
  • De Quervain tenosynovitis patients will be diagnosed based on the standard criteria, including pain and tenderness in the lateral wrist and a positive result for the Finkelstein test.

You may not qualify if:

  • History of undergoing physiotherapy modalities or corticosterone injection therapies for any reason during the past month.
  • Subjects with other neurological disorders rheumatologic diseases causing wrist pain.
  • Pregnancy.
  • History of fracture or surgery on the hand.
  • Severe trauma, and coagulation disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mostafa Gomaa Mahmoud

Cairo, Egypt

Location

MeSH Terms

Conditions

De Quervain Disease

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

Tendon EntrapmentTendinopathyMuscular DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Fatma S Amen

    Profeesor of Basic Science / Faculty of Physical therapy/ Cairo university

    PRINCIPAL INVESTIGATOR
  • Nabil M Ismail

    Assistant Prof. of Basic Science/ Faculty of Physical therapy/ Cairo university

    PRINCIPAL INVESTIGATOR
  • Doaa A Elimy

    Lecturer of Basic Science /Faculty of Physical therapy/ Cairo university

    PRINCIPAL INVESTIGATOR
  • Ahmed S Abd El Basset

    Lecturer of Radiology / Faculty of Medicine/ Beni Suef University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mostafa G Mahmoud, phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Extracorporeal Shockwave therapy \&Traditional physical therapy program
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

March 12, 2023

First Posted

March 23, 2023

Study Start

April 1, 2023

Primary Completion

April 1, 2024

Study Completion

August 1, 2024

Last Updated

March 23, 2023

Record last verified: 2023-03

Locations